3.32
price down icon7.78%   -0.28
after-market After Hours: 3.30 -0.02 -0.60%
loading

Citius Pharmaceuticals Inc Stock (CTXR) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
17.44%
10.97
9.3408 10.12 8.6721 10.69
Operating Income/Loss
17.44%
-10.97
-9.3408 -10.12 -8.6721 -10.69
Nonoperating Income/Loss
913.27%
2.57
0.2536 - - -
Income/Loss From Continuing Operations Before Tax
7.56%
-8.4002
-9.0872 -9.7999 -8.3353 -10.38
Income Tax Expense/Benefit, Deferred
0.00%
0.144
0.144 0.144 0.144 0.144
Income Tax Expense/Benefit
0.00%
0.144
0.144 0.144 0.144 0.144
Income/Loss From Continuing Operations After Tax
7.44%
-8.5442
-9.2312 -9.9439 -8.4793 -10.53
Net Income/Loss
7.44%
-8.5442
-9.2312 -9.9439 -8.4793 -10.53
Preferred Stock Dividends And Other Adjustments
-
- 1.1512 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.07%
159.07
158.96 2.5487 153.78 146.25
Diluted Average Shares
0.07%
159.07
158.96 2.5487 153.78 146.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 1.1512 - -
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):